Healthcare


 GeneTether Therapeutics Inc. (CSE: GTTX): Exclusive Licensing Agreement for STS-201 and Upcoming Private Placement

GeneTether Therapeutics Inc. (CSE: GTTX): Exclusive Licensing Agreement for STS-201 and Upcoming Private Placement

October 15, 2024 12:55 AM EDT| By Team Kalkine Media

Highlights,GeneTether enters exclusive licensing agreement for STS-201, targeting soft tissue sarcoma and other cancers.,The company plans a private placement to raise up to C$500,000 to support the STS-201 program.,John Rothman appointed as Chief Sc...

 Bausch + Lomb Corporation (NYSE/TSX: BLCO): FDA Approves enVista® Envy™ Intraocular Lens for Enhanced Vision

Bausch + Lomb Corporation (NYSE/TSX: BLCO): FDA Approves enVista® Envy™ Intraocular Lens for Enhanced Vision

October 15, 2024 12:35 AM EDT| By Team Kalkine Media

Highlights,New enVista Envy IOL offers a continuous range of vision and improved patient satisfaction.,Clinical trials demonstrate excellent outcomes with high tolerance for visual disturbances.,Limited availability in the U.S. soon, with broader lau...

 How Does Cigna Group Effectively Manage Its Debt?

How Does Cigna Group Effectively Manage Its Debt?

October 14, 2024 03:58 AM PDT| By Team Kalkine Media

Highlights,The Cigna Group operates within the healthcare sector, providing a wide range of health services.,The company manages a level of debt, which can impact overall financial stability.,Volatility and debt are often key considerations when eval...

 Theratechnologies Q3 Earnings: EPS Success and Revenue Outlook

Theratechnologies Q3 Earnings: EPS Success and Revenue Outlook

October 11, 2024 09:01 PM EDT| By Team Kalkine Media

Headlines,Theratechnologies reports third-quarter earnings with notable EPS performance.,Revenue growth outlook shows moderate expectations for the coming years.,Company faces challenges against industry benchmarks in Canada.,Theratechnologies,(TSX:T...

 How Does Quest PharmaTech’s AGM Shape the Future of Biotech?

How Does Quest PharmaTech’s AGM Shape the Future of Biotech?

October 11, 2024 07:07 PM EDT| By Team Kalkine Media

Highlights,Quest PharmaTech Inc. held its annual general meeting, electing four directors to the board.,The company reappointed its auditing firm during the meeting.,Quest PharmaTech granted stock options to directors and officers, pending TSX approv...

 What Are the Latest Corporate Moves by Simply Better Brands Corp.?

What Are the Latest Corporate Moves by Simply Better Brands Corp.?

October 11, 2024 07:01 PM EDT| By Team Kalkine Media

Highlights,Simply Better Brands Corp operates in the health and wellness sector.,The company recently issued common shares related to a previous agreement.,Simply Better Brands focuses on offering products in various wellness categories.,Simply Bette...

 What Does Conavi Medical's Recent Business Shift Mean for the Healthcare Industry?

What Does Conavi Medical's Recent Business Shift Mean for the Healthcare Industry?

October 11, 2024 06:14 PM EDT| By Team Kalkine Media

Highlights,Conavi Medical Corp. has completed a business combination, resulting in a reverse takeover.,The focus will be on advancing the Novasight Hybrid™ System for coronary procedures.,A concurrent private placement raised significant proceeds to...

 What Makes Ventripoint Diagnostics Ltd. Stand Out in Medical Technology?

What Makes Ventripoint Diagnostics Ltd. Stand Out in Medical Technology?

October 11, 2024 03:50 PM EDT| By Team Kalkine Media

Highlights:,Ventripoint Diagnostics Ltd. operates in the medical technology sector.,The company has submitted its VMS+4.0 software and hardware for approval under EU MDR.,Ventripoint Diagnostics Ltd.'s shares experienced a minor price change recently...

 What Makes Northwest Healthcare Properties REIT a Key Player in Healthcare?

What Makes Northwest Healthcare Properties REIT a Key Player in Healthcare?

October 11, 2024 03:44 PM EDT| By Team Kalkine Media

Highlights,Northwest Healthcare Properties REIT operates in the healthcare real estate sector.,Distribution for October 2024 declared at $0.03 per unit, payable on November 15, 2024.,The REIT’s shares have seen a rise recently, with trading reflectin...

 What Does Sagimet’s Recent Performance Reveal?

What Does Sagimet’s Recent Performance Reveal?

October 11, 2024 03:30 PM EDT| By Team Kalkine Media

Highlights:,Agimet Biosciences focuses on developing treatments for metabolic-related liver diseases.,Recent Phase 2b trial results for a new treatment targeting MASH were published in a medical journal.,The trial highlighted improvements in disease...

 Is Cardiol Therapeutics Poised for Breakthrough?

Is Cardiol Therapeutics Poised for Breakthrough?

October 11, 2024 03:29 PM EDT| By Team Kalkine Media

Highlights,Cardiol Therapeutics raised substantial funding through a public offering, aimed at advancing clinical development and supporting corporate initiatives.,The company plans to utilize the funds to further the development of CardiolRx, its le...

 Why Is Sernova Corp. Gaining Attention in Biotechnology?

Why Is Sernova Corp. Gaining Attention in Biotechnology?

October 11, 2024 03:22 PM EDT| By Team Kalkine Media

Highlights:,Sernova Corp. strengthens its executive team with new appointments.,Focus on improved communication and corporate governance.,Commitment to advancing research and clinical development programs.,Sernova Corp.,(TSX:SVA),is a life sciences c...

 Can MediPharm Labs Corp.'s Strategic Moves Elevate Its Market Position?

Can MediPharm Labs Corp.'s Strategic Moves Elevate Its Market Position?

October 11, 2024 01:56 PM EDT| By Team Kalkine Media

Highlights,MediPharm Labs Corp. operates in the Canadian Pharmaceuticals sector.,The company's price-to-sales (P/S) ratio stands at 0.8x, close to the industry median.,The stock's P/S ratio may indicate alignment with broader sector trends.,MediPharm...

 Cardiol Therapeutics Secures Significant Funding Through Successful Offering

Cardiol Therapeutics Secures Significant Funding Through Successful Offering

October 10, 2024 08:33 PM EDT| By Team Kalkine Media

Headlines,Cardiol Therapeutics successfully closes public offering.,Funds aimed at clinical development and working capital.,Canaccord Genuity serves as the bookrunner for the transaction.,Cardiol Therapeutics,(TSX:CRDL),has successfully concluded it...

 Why Is Algernon Pharmaceuticals' CEO Expanding His Stake in the Company?

Why Is Algernon Pharmaceuticals' CEO Expanding His Stake in the Company?

October 10, 2024 05:07 PM EDT| By Team Kalkine Media

Highlights:,Algernon Pharmaceuticals Inc. operates in the,healthcare sector,.,Christopher Moreau acquired 10,000 shares at 8 cents on October 10, 2024.,His total ownership now stands at 1,118,002 shares.,Algernon Pharmaceuticals Inc. is a clinical-st...

 WELL Health Boosts Efficiency with AI Scribe Success

WELL Health Boosts Efficiency with AI Scribe Success

October 09, 2024 07:28 PM EDT| By Team Kalkine Media

Highlights,WELL Health Technologies’ AI Voice solution significantly reduces the administrative workload for physicians, allowing them to focus more on patient care.,Many primary care providers express interest in continuing the use of AI scribes due...

 What Drives Hemostemix Inc.'s Strategic Growth in the Biotech Sector?

What Drives Hemostemix Inc.'s Strategic Growth in the Biotech Sector?

October 09, 2024 04:53 PM EDT| By Team Kalkine Media

Highlights,Hemostemix Inc. is part of the biotechnology sector, focusing on stem cell therapeutics.,CEO Thomas Smeenk sold shares in October, reducing his ownership to just over 258,000 shares.,The company's stem cell technology aims to treat degener...

 What Drives WELL Health Technologies Corp's Growing Presence in Digital Health?

What Drives WELL Health Technologies Corp's Growing Presence in Digital Health?

October 09, 2024 02:54 PM EDT| By Team Kalkine Media

Highlights,WELL Health Technologies Corp. focuses on reducing administrative burdens in primary care through AI-powered scribe technology.,The AI Scribe Evaluation Study, conducted by OntarioMD, demonstrates the effectiveness of this technology in en...

 How Did Delivra Health Brands Perform in 2024?

How Did Delivra Health Brands Perform in 2024?

October 09, 2024 02:27 PM EDT| By Team Kalkine Media

Highlights,Delivra Health Brands operates within the healthcare sector, focusing on wellness products.,The company reported a revenue increase compared to the previous fiscal year.,Delivra saw an improvement in profitability with a notable shift from...

 What Factors Are Shaping Cipher Pharmaceuticals Inc.'s Strategic Path?

What Factors Are Shaping Cipher Pharmaceuticals Inc.'s Strategic Path?

October 08, 2024 04:53 PM EDT| By Team Kalkine Media

Highlights:,Cipher Pharmaceuticals Inc. is a company within the specialty pharmaceutical sector.,Hamed Ghanei has been appointed as Chief Business Officer, bringing over 15 years of relevant experience.,Shares of Cipher Pharmaceuticals Inc. (T.CPH) s...

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.